{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:10Z","timestamp":1707524230359},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.7759\/cureus.14251","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T02:30:55Z","timestamp":1617330655000},"source":"Crossref","is-referenced-by-count":0,"title":["Periprocedural and In-Hospital Outcomes Among Percutaneous Coronary Intervention in Saphenous Vein Graft: A Retrospective Observational Study at a Tertiary Care Hospital in South Asian Country"],"prefix":"10.7759","author":[{"given":"Abdul","family":"Baqi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheema","family":"Saadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima H","year":"2008","unstructured":"Ueshima H, Sekikawa A, Miura K, et al.. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008, 118:2702-2709. 10.1161\/CIRCULATIONAHA.108.790048","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"54","author":"Kushner FG","year":"2009","unstructured":"Kushner FG, Hand M, Smith SC Jr, et al.. 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009, 54:2205-2241. 10.1016\/j.jacc.2009.10.015","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9149(76)90114-4","article-title":"Coronary artery bypass surgery for left main coronary artery disease","volume":"37","author":"McConahay DR","year":"1976","unstructured":"McConahay DR, Killen DA, McCallister BD, et al.. Coronary artery bypass surgery for left main coronary artery disease. Am J Cardiol. 1976, 37:885-889.","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1042\/CS20070243","article-title":"Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts","volume":"114","author":"Ribichini F","year":"2008","unstructured":"Ribichini F, Pugno F, Ferrero V, Wijns W, Vacca G, Vassanelli C, Virmani R. Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts. Clin Sci. 2008, 114:211-220. 10.1042\/CS20070243","journal-title":"Clin Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon GM","year":"1996","unstructured":"Fitzgibbon GM, Kafka HP, Leach AJ, et al.. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996, 28:616-626. 10.1016\/0735-1097(96)00206-9","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.95.4.868","article-title":"Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery","volume":"95","author":"Weintraub WS","year":"1997","unstructured":"Weintraub WS, Jones EL, Morris DC, King SB 3rd, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997, 95:868-877. 10.1161\/01.cir.95.4.868","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5223(19)37045-X","article-title":"Fifteen hundred coronary reoperations. Results and determinants of early and late survival","volume":"93","author":"Lytle B","year":"1987","unstructured":"Lytle B, Loop F, Cosgrove D, et al.. Fifteen hundred coronary reoperations. Results and determinants of early and late survival. J Thorac Cardiovasc Surg. 1987, 93:847-859.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.03.018","article-title":"Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry","volume":"4","author":"Brilakis ES","year":"2011","unstructured":"Brilakis ES, Rao SV, Banerjee S, et al.. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2011, 4:844-850. 10.1016\/j.jcin.2011.03.018","journal-title":"JACC Cardiovasc Interv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.001","article-title":"ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)","volume":"47","author":"Smith SC Jr","year":"2006","unstructured":"Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al.. ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006, 47:e1-121. 10.1016\/j.jacc.2005.12.001","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert JS","year":"2000","unstructured":"Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000, 36:959-969. 10.1016\/s0735-1097(00)00804-4","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip DE","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, et al.. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007, 115:2344-2351. 10.1161\/CIRCULATIONAHA.106.685313","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro JH","year":"1987","unstructured":"Chesebro JH, Knatterud G, Roberts R, et al.. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987, 76:142-154. 10.1161\/01.CIR.76.1.142","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.01.034","article-title":"Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the veterans affairs clinical assessment, reporting, and tracking program","volume":"9","author":"Brilakis ES","year":"2016","unstructured":"Brilakis ES, O'Donnell CI, Penny W, et al.. Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the veterans affairs clinical assessment, reporting, and tracking program. JACC Cardiovasc Interv. 2016, 9:884-893. 10.1016\/j.jcin.2016.01.034","journal-title":"JACC Cardiovasc Interv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"53","author":"Brilakis ES","year":"2009","unstructured":"Brilakis ES, Lichtenwalter C, de Lemos JA, et al.. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol. 2009, 53:919-928. 10.1016\/j.jacc.2008.11.029","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61255-5","article-title":"Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial","volume":"378","author":"Mehilli J","year":"2011","unstructured":"Mehilli J, Pache J, Abdel-Wahab M, et al.. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet. 2011, 378:1071-1078. 10.1016\/S0140-6736(11)61255-5","journal-title":"Lancet"},{"key":"ref16","article-title":"Comparison of drug-eluting stents with bare-metal stents for PCI of saphenous vein graft lesions: systematic review and meta-analysis","volume":"28","author":"Mosleh W","year":"2016","unstructured":"Mosleh W, Gandhi S, Elsiddig M, et al.. Comparison of drug-eluting stents with bare-metal stents for PCI of saphenous vein graft lesions: systematic review and meta-analysis. J Invasive Cardiol. 2016, 28:e139-e169.","journal-title":"J Invasive Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24781","article-title":"Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions","volume":"82","author":"Ybarra LF","year":"2013","unstructured":"Ybarra LF, Ribeiro HB, Pozetti AH, et al.. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions. Catheter Cardiovasc Interv. 2013, 82:E856-E863. 10.1002\/ccd.24781","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","article-title":"Peri-procedural outcome of saphenous vein graft intervention","volume":"24","author":"Shakoor T","year":"2012","unstructured":"Shakoor T, Mallick NH, Noeman A. Peri-procedural outcome of saphenous vein graft intervention. J Ayub Medical Coll Abbottabad. 2012, 24:39-42.","journal-title":"J Ayub Medical Coll Abbottabad"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.2174\/157489012801227265","article-title":"Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus","volume":"7","author":"Sharma S","year":"2012","unstructured":"Sharma S, A Lardizabal J, Singh S, et al.. Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus. Recent Pat Cardiovasc Drug Discov. 2012, 7:152-159.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.10.003","article-title":"Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"4","author":"Brilakis ES","year":"2011","unstructured":"Brilakis ES, Lichtenwalter C, Abdel-karim AR, et al.. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv. 2011, 4:176-182. 10.1016\/j.jcin.2010.10.003","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53868-periprocedural-and-in-hospital-outcomes-among-percutaneous-coronary-intervention-in-saphenous-vein-graft-a-retrospective-observational-study-at-a-tertiary-care-hospital-in-south-asian-country","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:13Z","timestamp":1707507073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53868-periprocedural-and-in-hospital-outcomes-among-percutaneous-coronary-intervention-in-saphenous-vein-graft-a-retrospective-observational-study-at-a-tertiary-care-hospital-in-south-asian-country"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.14251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}